BCR-ABL tyrosine kinase inhibitors

472 Pill - yellow round, 9mm

Pill with imprint 472 is Yellow, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Sun Pharma Global FZE.

Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Acute Lymphoblastic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imatinib (Imatinib [ im-ma-ta-nib ])-472-100 mg-Yellow-Round
Imatinib (Imatinib [ im-ma-ta-nib ])-472-100 mg-Yellow-Round

Imatinib
Generic Name: imatinib [ im-ma-ta-nib ]
Imprint: 472
Strength: 100 mg
Color: Yellow
Size: 9.00 mm
Shape: Round
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 47335-0472
Inactive Ingredients: Microcrystalline cellulose, Mannitol, Copovidone, Crospovidone, Magnesium stearate, Hypromelloses, Ferric oxide yellow, Polyethylene glycol, Titanium dioxide, FD&C Yellow No. 6, Ferric oxide red,
Latest News
Related Drugs